Profile data is unavailable for this security.
About the company
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company developing medicine tests for immune health based on the EpiSwitch 3D genomics platform. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch CST, EpiSwitch PSE, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test, which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch CST is a blood test for the prediction of COVID-19 severity in any adult. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The EpiSwitch platform offers reproducibly translating 3D genome regulation for clinical application. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
- Revenue in GBP (TTM)617.00k
- Net income in GBP-11.11m
- Incorporated2007
- Employees45.00
- LocationOxford Biodynamics PLC26 Beaumont StreetOXFORD OX4 2WBUnited KingdomGBR
- Phone+44 18 6551 8910Fax+44 18 6551 1418
- Websitehttps://www.oxfordbiodynamics.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
ValiRx Plc | 9.60k | -2.04m |
TheraCryf PLC | 396.00k | -3.14m |
Fusion Antibodies PLC | 1.14m | -2.23m |
IXICO PLC | 6.00m | -1.87m |
ImmuPharma PLC | -69.96k | -2.46m |
Genflow Biosciences PLC | 0.00 | -1.63m |
Synairgen plc | 0.00 | -6.92m |
Cizzle Biotechnology Holdings PLC | 0.00 | -1.72m |
LungLife AI Inc | 21.69k | -3.34m |
Oxford Biodynamics PLC | 617.00k | -11.11m |
OptiBiotix Health PLC | 644.00k | -2.04m |
Hemogenyx Pharmaceuticals PLC | 0.00 | -6.69m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Vulpes Investment Management Pte Ltd.as of 08 Apr 2024 | 29.65m | 9.51% |
Arbuthnot Latham & Co. Ltd.as of 01 Jul 2024 | 26.24m | 8.41% |
Unicorn Asset Management Ltd.as of 08 Apr 2024 | 25.13m | 8.06% |
Lombard Odier Asset Management (Europe) Ltd.as of 21 Aug 2024 | 15.75m | 5.05% |
KW Investment Management Ltd.as of 01 Jul 2024 | 14.20m | 4.55% |
Cantor Fitzgerald Europeas of 05 Apr 2024 | 8.02m | 2.57% |
Investec Wealth & Investment Ltd.as of 15 Jan 2024 | 7.32m | 2.35% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Jul 2024 | 5.47m | 1.75% |
Armistice Capital LLCas of 04 Feb 2022 | 4.93m | 1.58% |
Chelverton Asset Management Ltd.as of 01 Jul 2024 | 4.33m | 1.39% |